Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon, Parabricks to Offer Genomic Data Tech on Google Cloud Platform

NEW YORK (GenomeWeb) — Genomenon and Parabricks have signed agreements to offer certain of their genomic data technologies on the Google Cloud Platform, the informatics companies announced today.

According to Ann Arbor, Michigan-based Genomenon, its cited variants reference datasets — which are generated through the company's Mastermind search engine of genomic literature and can be used to identify genomic variants that have been cited in scientific publications — will be available in Google's BigQuery data warehouse.

Meanwhile, Parabricks, also based in Ann Arbor, said that it has launched a new software suite for primary and secondary analysis of sequencing data on the Google Cloud Platform Marketplace. According to the firm, the graphics processing unit-based software solution can produce variant calls from raw sequencing data in less than an hour.

"The Parabricks solution is widely used in in-house clusters, and with the growing adoption of cloud computing in genomics it was important for us to provide an easy to use cloud solution," Parabricks CEO Mehrzad Samadi said in a statement. "Google Cloud Platform has a strong user base in the genomics market and our solution can greatly benefit that base."

Earlier this month, Genomenon signed an agreement to integrate the Mastermind search engine into LifeMap Sciences' GeneCards knowledgebase. Last year, Microsoft partnered with Parabricks to offer its sequence analysis software on the Azure cloud.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.